Stocks HNST Financial statements
Financial statementsHonest Company, Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Honest Company, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 236 | 301 | 319 | 314 | 344 | 378 | 371 |
| Cost of revenue | 160 | 193 | 209 | 221 | 244 | 234 | 248 |
| Gross profit | 75.9 | 108 | 109 | 92.3 | 101 | 145 | 124 |
| Research and development | 5.14 | 5.71 | 7.68 | 7 | 6.21 | 6.85 | 7.35 |
| Selling, general and administrative | 70.3 | 71.3 | 84.1 | 87.3 | 94.6 | 99 | 79.5 |
| Operating expenses | 107 | 121 | 146 | 142 | 139 | 151 | 142 |
| Operating income | -31.5 | -13.5 | -36.8 | -49.8 | -38.9 | -6.33 | -18.5 |
| Other non-operating income | 0.43 | -0.84 | -1.78 | 0.87 | -0.25 | 0.28 | 2.98 |
| Pre-tax income | -31 | -14.4 | -38.6 | -48.9 | -39.2 | -6.05 | -15.5 |
| Income tax | 0.06 | 0.09 | 0.08 | 0.11 | 0.08 | 0.08 | 0.2 |
| Net income | -31.1 | -14.5 | -38.7 | -49 | -39.2 | -6.12 | -15.7 |
| EBITDA | -23.8 | -8.69 | -32.7 | -47 | -36.2 | -3.49 | -15.6 |
| EPS, basic | -0.92 | -0.43 | -0.43 | -0.53 | -0.42 | -0.06 | -0.14 |
| EPS, diluted | -0.92 | -0.43 | -0.43 | -0.53 | -0.42 | -0.06 | -0.14 |
| Shares, basic (weighted) | 33.9 | 34.1 | 71.1 | 92.2 | 94.5 | 100 | 111 |
| Shares, diluted (weighted) | 33.9 | 34.1 | 71.1 | 92.2 | 94.5 | 100 | 111 |
| Dividend per share | 0.42 | 0.42 |
Balance sheet
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 13.5 | 29.3 | 50.8 | 9.52 | 32.8 | 75.4 | 89.6 |
| Short-term investments | 34.4 | 42.4 | |||||
| Receivables | 22.8 | 31.8 | 42.3 | 43.1 | 43.5 | 33.8 | |
| Inventory | 76.7 | 75.7 | 116 | 73.5 | 85.3 | 72.5 | |
| Other current assets | 8.66 | 13.2 | 16 | 8.37 | 9.74 | 6.59 | |
| Total current assets | 174 | 214 | 189 | 158 | 214 | 202 | |
| Property, plant and equipment | 56.7 | 53 | 14.3 | 13.5 | 11.4 | 7.48 | |
| Lease right-of-use assets | 29.9 | 23.7 | 17.2 | 11.4 | |||
| Goodwill | 2.23 | 2.23 | 2.23 | 2.23 | 2.23 | 2.27 | |
| Intangible assets | 0.51 | 0.44 | 0.37 | 0.31 | 0.24 | 0.16 | |
| Other non-current assets | 1.54 | 3.18 | 4.58 | 4.14 | 2.38 | 1.72 | |
| Total assets | 241 | 273 | 241 | 202 | 247 | 225 | |
| Accounts payable | 31.1 | 28.7 | 24.8 | 22.3 | 22.8 | 15.1 | |
| Accrued liabilities | 22.2 | 19 | 38 | 32.2 | 35.9 | 35.7 | |
| Deferred revenue | 0.72 | 0.73 | 0.82 | 2.21 | 1.21 | 0 | |
| Total current liabilities | 54.1 | 48.5 | 63.6 | 56.7 | 59.9 | 50.8 | |
| Lease liabilities | 29.8 | 21.7 | 13.2 | 4.92 | |||
| Other non-current liabilities | 8.66 | 7.49 | 0.82 | 0.03 | 0 | ||
| Total liabilities | 101 | 93.5 | 94.2 | 78.5 | 73.1 | 55.7 | |
| Paid-in capital | 116 | 571 | 586 | 602 | 659 | 671 | |
| Retained earnings | -353 | -392 | -440 | -479 | -485 | -501 | |
| Treasury stock | 0 | ||||||
| Other comprehensive income | 0.09 | -0.04 | -0.03 | 0 | |||
| Shareholders' equity | -230 | -237 | 179 | 146 | 123 | 174 | 170 |
| Total equity | -230 | -237 | 179 | 146 | 123 | 174 | 170 |
| Total liabilities and equity | 241 | 273 | 241 | 202 | 247 | 225 | |
| Shares outstanding | 34.1 | 91.5 | 92.9 | 95.9 | 109 | 113 |
Cash flow statement
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Net income | -31.1 | -14.5 | -38.7 | -49 | -39.2 | -6.12 | -15.7 |
| Depreciation and amortization | 7.67 | 4.85 | 4.15 | 2.75 | 2.74 | 2.84 | 2.9 |
| Stock-based compensation | 8.38 | 7.91 | 16.8 | 15.1 | 15.8 | 15.7 | 10.5 |
| Deferred income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in receivables | -2.46 | 1.46 | -8.99 | -10.8 | -0.68 | -0.38 | 10.2 |
| Change in inventory | 4.65 | -24.1 | 1 | -39 | 43.5 | -10.9 | -7.47 |
| Cash from operations | -20 | -12.1 | -38.2 | -76.3 | 19.4 | 1.54 | 15.1 |
| Capital expenditures | -0.66 | -0.2 | -0.22 | -1.62 | -1.84 | -0.53 | -1.51 |
| Purchases of investments | -74.4 | -22.5 | -65.3 | -12.8 | 0 | 0 | |
| Sales and maturities of investments | 81.3 | 53.5 | 29.5 | 49.4 | 5.68 | 0 | 0 |
| Cash from investing | 11 | 36.7 | -8.62 | 35 | 3.84 | -0.53 | -1.51 |
| Stock issued | 0.25 | 0.04 | 5.73 | 0.12 | 0 | 41.5 | 0.38 |
| Dividends paid | 0 | 0 | -35 | 0 | 0 | ||
| Cash from financing | -0.31 | -0.97 | 60.4 | 0.04 | 0.12 | 41.6 | 0.54 |
| Net change in cash | -9.29 | 23.7 | 13.6 | -41.3 | 23.3 | 42.6 | 14.1 |
| Free cash flow | -20.7 | -12.3 | -38.4 | -77.9 | 17.5 | 1.01 | 13.6 |
| Interest paid | 1.72 | 1.84 | 1.8 | 0.01 | 0 | 0 | 0 |
| Income taxes paid | 0.08 | 0.1 | 0.08 | 0.1 | 0.12 | 0.09 | 0.11 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 35.7% | Gross profit / revenue. |
| Operating margin | -4.4% | Operating income / revenue. |
| EBITDA margin | -3.6% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | -3.5% | Pre-tax income / revenue. |
| Net margin | -3.6% | Net income / revenue. |
| FCF margin | 15.4% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 16.5% | Cash from operations / revenue. |
| Return on equity (ROE) | -7.3% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | -5.5% | Net income / average total assets. |
| Return on invested capital (ROIC) | -19.3% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 2.1% | Research and development expense / revenue. |
| SG&A / revenue | 20.6% | Selling, general and administrative expense / revenue. |
| Stock-based pay / revenue | 3.2% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 1.1% | Capital expenditures / revenue. |
| D&A / revenue | 0.8% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | -1.9% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 5.8% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 4.3% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | -14.4% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 10.3% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 2.8% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | 881.2% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow growth, 1y | 1,246.0% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Book value growth, 1y | -2.7% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 5.0% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets growth, 1y | -8.9% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | -2.2% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | -1.3% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | 10.9% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 6.4% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 26.7% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 3.94x | Current assets / current liabilities. |
| Quick ratio | 2.83x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 2.08x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 24.1% | Total liabilities / total assets. |
| Working capital | $149.8M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 1.1% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $164.6M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 1.55x | Revenue / average total assets. |
| Fixed asset turnover | 41.5x | Revenue / average property, plant and equipment. |
| Inventory turnover | 4.43x | Cost of revenue / average inventory. |
| Days inventory | 82 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 8.98x | Revenue / average receivables. |
| Days sales outstanding | 41 days | 365 x average receivables / revenue. |
| Days payables | 30 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 93 days | Days inventory + days sales outstanding - days payables. |
| Capex / operating cash flow | 6.8% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | -$0.11 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $3.02 | Revenue / diluted weighted shares. |
| FCF per share | $0.47 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $0.50 | Cash from operations / diluted weighted shares. |
| Book value per share | $1.46 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $1.44 | Tangible book value / shares outstanding. |
| Cash per share | $0.92 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $567.5M | Share price x shares outstanding. |
| Enterprise value | $461.6M | Market cap + total debt - cash - short-term investments. |
| P/S | 1.66x | Market cap / revenue. |
| P/B | 3.40x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 3.45x | Market cap / tangible book value, when positive. |
| P/FCF | 10.8x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 10.0x | Market cap / cash from operations, when positive. |
| EV/Sales | 1.35x | Enterprise value / revenue. |
| EV/FCF | 8.76x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 9.3% | Free cash flow / market cap. |
| Earnings yield | -2.1% | Net income / market cap (the inverse of P/E). |
What was Honest Company, Inc.'s revenue in fiscal 2025?
Honest Company, Inc. reported revenue of $371.3M for fiscal 2025, 1.9% lower than the year before.
Was Honest Company, Inc. profitable in fiscal 2025?
No. It reported a net loss of $15.7M.
How much free cash flow did Honest Company, Inc. generate in fiscal 2025?
Cash from operations of $15.1M minus capital expenditures of $1.5M left free cash flow of $13.6M.